Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03346694 · ClinicalTrials.gov registry record · NA
Reducing Surgical Site Infection Rates Using an Alternative Sternal Dressing
A NA study of Wound of Skin, sponsored by Stanford University.
- Recruiting
- Registry status
- NA
- Development phase
- 660
- Enrollment target
- 1
- Study location
NCT03346694: Recruiting NA study of Wound of Skin, sponsored by Stanford University.
NCT03346694 is a NA study of Wound of Skin that is actively recruiting participants, run by Stanford University. The registered enrollment target is 660 participants, above the 54-participant average among 8 other Wound of Skin trials with a reported enrollment target (1122% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03346694, a NA study of Wound of Skin, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- NA
- Development phase
- 660 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate two alternative dressings compared to a standard Island dressing presently in use at Stanford Hospital to determine reductions in surgical site infection (SSI) rates among cardiac surgery patients. Cardiovascular surgery patients who will have a sternotomy incision as a routine part of their surgery will be approached to voluntarily participate. Participants will be randomized to one of three dressing to determine which dressing has the lowest rate of sternal wound infection. The investigators will also assess the impact of alternative dressing use on hospital 30-day readmission rates related to SSI.
Primary Outcome
evaluate alternative dressings to determine reductions in surgical site infection (SSI) rates among cardiac surgery patients
Conditions Studied
Interventions
- DEVICE Standard Island Dressing
- DEVICE Prevena Negative Pressure wound dressing
- DEVICE Mepilex Border Post-Op Ag
Study Locations (1)
California
- Stanford Healthcare - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 660 participants |
| Start Date | 2018-05-01 |
| Est. Completion | 2035-05-01 |
| Phase | NA |
What NCT03346694 shows while recruiting
NCT03346694 is an interventional study that assigns participants to a tested intervention. The registered 660 participants enrollment target is mid-sized for trials with a published cap, above the 54-participant average among 8 other Wound of Skin trials with a reported enrollment target (1122% higher).
The record links to 1 condition, with Wound of Skin appearing as the primary indexed condition, and to 3 interventions - of which Standard Island Dressing is the first listed.
NCT03346694 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03346694 about?
NCT03346694 is a clinical study titled "Reducing Surgical Site Infection Rates Using an Alternative Sternal Dressing". This study will evaluate two alternative dressings compared to a standard Island dressing presently in use at Stanford Hospital to determine reductions in surgical site infection (SSI) rates among cardiac surgery patients. Cardiovascular surgery patients who will have a sternotomy incision as a rout...
What is the current status of trial NCT03346694?
This trial is currently recruiting. It is a NA study. The enrollment target is 660 participants. The study started on 2018-05-01. Estimated completion is 2035-05-01.
What conditions does trial NCT03346694 study?
This clinical trial studies the following conditions: Wound of Skin.
What interventions are being tested in trial NCT03346694?
The interventions under investigation include: Standard Island Dressing (DEVICE), Prevena Negative Pressure wound dressing (DEVICE), Mepilex Border Post-Op Ag (DEVICE).
Who is sponsoring clinical trial NCT03346694?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03346694 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Wound of Skin
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03346694's enrollment target sits among peer trials
660 1st of 8 higher than 8 of 8 other Wound of Skin trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Wound of Skin trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.
RECRUITING · NA
-
Suprathel® Use During Prolonged Field Care to Promote Healing and Reduce the Need for Grafting of Burn Wounds
RECRUITING · NA
-
A Clinical Investigation to Follow the Progress of Exuding Chronic Venous Leg Ulcers Using a Non-Bordered Foam Dressing
RECRUITING · NA
-
Influence of Sun Protection and Linear Repair of Cutaneous Surgical Defects
ACTIVE NOT RECRUITING · NA
-
Pilot Study: KeraStat® Gel for Topical Delivery of Morphine for Management of Non-Healing, Painful Open Wounds and Ulcers
RECRUITING · Phase 4
-
4-aminopyridine for Skin Wound Healing
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01185132 · 660 participants · Phase 3
Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy
- NCT05407636 · 660 participants · Phase 3
Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD
- NCT05470205 · 660 participants · Phase 3
Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension; Renewal
- NCT05677880 · 660 participants
Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI